- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
195
Companies with a Value score of at least 3, ordered by Value score
195 companies
IQVIA Holdings
Market Cap: US$30.8b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
0JDM
US$184.53
7D
-2.7%
1Y
-21.5%
Zoetis
Market Cap: US$62.8b
Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
0M3Q
US$141.39
7D
-4.0%
1Y
-27.0%
Roche Holding
Market Cap: CHF 223.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
0QQ6
CHF 273.00
7D
-0.7%
1Y
-5.9%
Roche Holding
Market Cap: CHF 223.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
0QOK
CHF 259.95
7D
-0.5%
1Y
-4.2%
Basilea Pharmaceutica
Market Cap: CHF 568.3m
A Swiss commercial-stage biotech company focused on developing and commercializing treatments for severe bacterial and fungal infections.
0QNA
CHF 46.28
7D
1.0%
1Y
-2.3%
Photocure
Market Cap: NOK 1.8b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHOO
NOK 57.70
7D
0%
1Y
n/a
Bionano Genomics
Market Cap: US$12.5m
Provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
0A4K
US$5.25
7D
0%
1Y
-89.9%
Egetis Therapeutics
Market Cap: SEK 2.0b
A pharmaceutical company, focuses on projects in late-stage development for the treatment of serious diseases with unmet medical needs in the orphan drug segment.
0ABW
SEK 5.10
7D
0%
1Y
n/a
Gilead Sciences
Market Cap: €141.9b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
GISD
€94.91
7D
0%
1Y
27.1%
Roche Holding
Market Cap: CHF 223.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROZ
CHF 273.40
7D
-0.2%
1Y
-5.8%
Eurofins Scientific
Market Cap: €11.0b
Provides various analytical testing and laboratory services worldwide.
ERFP
€61.82
7D
-1.1%
1Y
14.7%
Waters
Market Cap: US$17.8b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
0LTI
US$294.78
7D
-4.1%
1Y
-13.4%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
0ILL
€58.34
7D
-1.7%
1Y
-18.9%
Santhera Pharmaceuticals Holding
Market Cap: CHF 141.6m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
0QN1
CHF 11.26
7D
-21.3%
1Y
25.0%
Grifols
Market Cap: €7.4b
Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
0RDU
€12.25
7D
2.9%
1Y
24.4%
Zealand Pharma
Market Cap: DKK 33.1b
A biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States.
0NZU
DKK 458.22
7D
-0.4%
1Y
-47.8%
Novavax
Market Cap: US$1.4b
A biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally.
0A3S
US$8.70
7D
2.5%
1Y
-28.1%
Santhera Pharmaceuticals Holding
Market Cap: CHF 141.6m
A specialty pharmaceutical company, together with its subsidiaries, develops and sells medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the Europe, North America, and Asia.
SANNZ
CHF 10.96
7D
-23.2%
1Y
22.5%
Tecan Group
Market Cap: CHF 2.0b
Provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally.
TECNZ
CHF 155.00
7D
-1.9%
1Y
-41.9%
Roche Holding
Market Cap: CHF 223.1b
Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.
ROGZ
CHF 260.60
7D
0.1%
1Y
-4.1%
Diaceutics
Market Cap: UK£135.4m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.60
7D
10.7%
1Y
19.9%
Euroapi
Market Cap: €288.1m
Develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.
0EAP
€2.99
7D
-1.8%
1Y
-25.7%
Bonesupport Holding
Market Cap: SEK 19.8b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEXS
SEK 296.60
7D
-3.7%
1Y
-9.1%
ArcticZymes Technologies
Market Cap: NOK 1.3b
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing.
0DRV
NOK 25.70
7D
0.8%
1Y
43.7%
Siegfried Holding
Market Cap: CHF 3.5b
Engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide.
0QQO
CHF 81.10
7D
-4.5%
1Y
-30.2%
Vanda Pharmaceuticals
Market Cap: US$289.5m
A biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide.
0LKB
US$4.98
7D
10.2%
1Y
5.2%
Goodbody Health
Market Cap: UK£80.3k
Goodbody Health Inc., a wellness company, provides health and wellness range of products and services in the United Kingdom.
GDBY
UK£0.0025
7D
-16.7%
1Y
-99.0%
Adocia
Market Cap: €145.0m
A clinical-stage biotechnology company, researches and develops formulations of pre-approved therapeutic proteins and peptides for the treatment of diabetes and other metabolic diseases.
ADOCP
€7.82
7D
0%
1Y
133.4%
Faes Farma
Market Cap: €1.3b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.
FAEE
€4.15
7D
0%
1Y
n/a
GenSight Biologics
Market Cap: €23.4m
A clinical-stage biotechnology company, discovers, develops, and commercializes novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system.
0RIM
€0.14
7D
-6.0%
1Y
-59.8%
Shield Therapeutics
Market Cap: UK£78.4m
A commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs.
STX
UK£0.074
7D
-5.4%
1Y
89.2%
Eli Lilly
Market Cap: €670.6b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLYD
€634.10
7D
-2.7%
1Y
n/a
Bonesupport Holding
Market Cap: SEK 19.8b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
0RQO
SEK 305.96
7D
1.6%
1Y
3.5%
UCB
Market Cap: €38.9b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCBB
€205.55
7D
0.5%
1Y
22.2%
Eurofins Scientific
Market Cap: €11.0b
Provides various analytical testing and laboratory services worldwide.
0MV5
€61.93
7D
-0.5%
1Y
12.7%
Qiagen
Market Cap: €9.8b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
0RLT
€38.54
7D
-0.9%
1Y
-5.8%